1. Home
  2. GVH vs NOTV Comparison

GVH vs NOTV Comparison

Compare GVH & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Globavend Holdings Limited

GVH

Globavend Holdings Limited

HOLD

Current Price

$6.00

Market Cap

11.5M

Sector

N/A

ML Signal

HOLD

Logo Inotiv Inc.

NOTV

Inotiv Inc.

HOLD

Current Price

$0.31

Market Cap

10.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GVH
NOTV
Founded
2016
1974
Country
Australia
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
10.8M
IPO Year
2023
1997

Fundamental Metrics

Financial Performance
Metric
GVH
NOTV
Price
$6.00
$0.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$80.00
$1.50
AVG Volume (30 Days)
150.7K
960.0K
Earning Date
02-17-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
49.64
EPS
N/A
N/A
Revenue
N/A
$547,656,000.00
Revenue This Year
$102,768.97
$5.28
Revenue Next Year
N/A
$5.42
P/E Ratio
$0.74
N/A
Revenue Growth
N/A
511.19
52 Week Low
$0.03
$0.22
52 Week High
$10.74
$3.31

Technical Indicators

Market Signals
Indicator
GVH
NOTV
Relative Strength Index (RSI) 85.92 52.74
Support Level $4.02 $0.24
Resistance Level N/A $0.41
Average True Range (ATR) 0.65 0.03
MACD 0.23 0.00
Stochastic Oscillator 89.05 44.01

Price Performance

Historical Comparison
GVH
NOTV

About GVH Globavend Holdings Limited

Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

Share on Social Networks: